OOIR: Observatory of International Research

Papers

(The H4-Index of Globalization and Health is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Comprehensive Medical Support in Complex Emergencies (CMSCE): pilot course review	104
Correction: Assessing the effects of mining projects on child health in sub-Saharan Africa: a multi-country analysis	71
North Korea’s COVID-19 policy dilemma: epidemic prevention conflicting with trade	71
Cross-border utilization of cancer care by patients in the US and Mexico – a survey of Mexican oncologists	70
National governance and excess mortality due to COVID-19 in 213 countries: a retrospective analysis and perspectives on future pandemics	66
Rain, rain, go away, come again another day: do climate variations enhance the spread of COVID-19?	62
Implementation and challenges to preventing the re-establishment of malaria in China in the COVID-19 era	61
Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and response	53
Capturing sources of health system legitimacy in fragmented conflict zones under different governance models: a case study of northwest Syria	50
Constructing public–private partnerships to undermine the public interest: critical discourse analysis of Working Together published by the International Alliance for Responsible Drinking	47
The alcohol industry’s involvement with road safety NGOs	45
From isolation to revival: trade recovery amid global health crises	38
Securing the rights and health of domestic workers: the importance of ratifying the ILO’s C189	38
Lobbying and nutrition policy in Canada: a quantitative descriptive study on stakeholder interactions with government officials in the context of Health Canada’s Healthy Eating Strategy	38
Global smoking-related deaths averted due to MPOWER policies implemented at the highest level between 2007 and 2020	38
Characteristics and outcomes of the drug patent linkage system in China	36
Universal coverage of the first antenatal care visit but poor continuity of care across the maternal and newborn health continuum among Nepalese women: analysis of levels and correlates	36
The politics of glyphosate regulation: lessons from Sri Lanka’s short-lived ban	36
Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region	34
Reserve antibiotics: overcoming limitations of evidence generated from regulatory approval trials	33
Learning from COVID-19: government leaders’ perspectives to improve emergency risk communication	33
Food insecurity, COVID-19 and diets in Fiji – a cross-sectional survey of over 500 adults	32
Financing of health services for undocumented immigrants in Iran: common challenges and potential solutions	31
Vaccine nationalism will persist: global public goods need effective engagement of global citizens	31
Future health expenditure in the BRICS countries: a forecasting analysis for 2035	30

“We have to look deeper into why”: perspectives on problem identification and prioritization of women’s and girls’ health across United Nations agencies	30
“When there is no money, that is when I vomit blood”: the domino effect and the unfettered lethal exploitation of Black labor on Dominican sugar plantations	29
Incremental financial costs of strengthening large-scale child nutrition programs in Bangladesh, Ethiopia, and Vietnam: retrospective expenditure analysis	29
Translating global evidence into local implementation through technical assistance: a realist evaluation of the Bloomberg philanthropies initiative for global Road safety	29
Safeguarding health in bilateral investment treaties: the Uruguayan experience	29